Loading data for APM — first visit, this takes a few seconds.
Aptorum Group Ltd (APM)
NGM: APM
· 实时价格 · USD
0.70
+0.70 (n/a)
收盘价： Sep 10, 2026, 10:53 PM
股价、关键数字和最新消息，都在这一页。
Aptorum Group Ltd（APM）股价、分析与数据
暂无数据
| 买价 | 0.5 |
| 市值 | 570K |
| 营收（TTM） | n/a |
| 净利润（TTM） | -1.36M |
| 0.17 | |
| -1.9 | |
| n/a | |
| -0.99 | |
| 市净率（TTM） | 0.02 |
| 市销率（TTM） | 0.00 |
| 财报日期 | n/a |
| 卖价 | 0.83 |
| 成交量 | 195,145 |
| 20日均量 | 81,270 |
| 开盘价 | 0.70 |
| 前收盘价 | 0.00 |
| 日内区间 | 0.60 - 0.74 |
| 52周区间 | 0.60 - 44.70 |
| 分析师 | n/a |
| 目标价 | n/a |
| 分红 | n/a |
| 除息日 | n/a |
关于 APM
Aptorum Group Limited, through its subsidiaries, a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases. Its pipeline products include SACT-1, a repurposed drug candidate, which is in phase 1 clinical trial to treat neuroblastoma and other cancer types; ALS-4, a repurposed small molecule, which is in phase 1 clinical trial for the t...
公司完整简介财报意外
Aptorum Ltd 已于 Invalid Date 发布季度财报：
- 营收为 n/a 低于预期 $0, ， NaN% 同比增长.
- 每股收益为 低于预期 , ， NaN% 同比增长.
第 1 页，共 2 页